(SNDK) Sandisk - Ratings and Ratios
Solid State Drives, Flash Embedded Storage, Removable Cards, USB Drives
EPS (Earnings per Share)
Revenue
Dividends
Currently no dividends paid| Risk via 5d forecast | |
|---|---|
| Volatility | 156% |
| Value at Risk 5%th | 189% |
| Relative Tail Risk | -26.57% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 3.29 |
| Alpha | 965.51 |
| CAGR/Max DD | 33.79 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.574 |
| Beta | 2.461 |
| Beta Downside | 3.140 |
| Drawdowns 3y | |
|---|---|
| Max DD | 47.50% |
| Mean DD | 16.17% |
| Median DD | 16.09% |
Description: SNDK Sandisk January 14, 2026
SanDisk Corp (NASDAQ:SNDK) designs, manufactures, and sells NAND-flash-based data storage solutions across a broad product set-including SSDs for PCs and consoles, embedded flash for mobile and automotive, and removable media-serving OEMs, cloud providers, and consumer channels worldwide from its Milpitas, California headquarters.
Key recent metrics: Q3 2024 revenue reached roughly $2.2 billion, reflecting an 8% year-over-year increase driven by strong demand for data-center SSDs; the company’s average selling price per gigabyte fell 4% as newer 176-layer TLC/QLC wafers entered production, boosting gross margins to about 38%. Sector-wide, global NAND shipments are projected to grow 12% in 2024, propelled by AI-related workloads and the rollout of 5G-enabled IoT devices, while supply-chain constraints on silicon wafers remain a headwind.
For a deeper dive into SanDisk’s valuation metrics and competitive positioning, explore the ValueRay platform.
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income (-1.74b TTM) > 0 and > 6% of Revenue (6% = 466.8m TTM) |
| FCFTA 0.02 (>2.0%) and ΔFCFTA 4.69pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 44.58% (prev 41.58%; Δ 3.00pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.04 (>3.0%) and CFO 478.0m > Net Income -1.74b (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 3.29 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (149.0m) change vs 12m ago 3.47% (target <= -2.0% for YES) |
| Gross Margin 27.93% (prev 28.32%; Δ -0.39pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 58.41% (prev 50.49%; Δ 7.92pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -20.06 (EBITDA TTM -1.40b / Interest Expense TTM 77.0m) >= 6 (WARN >= 3) |
Altman Z'' -0.02
| (A) 0.27 = (Total Current Assets 4.98b - Total Current Liabilities 1.52b) / Total Assets 12.75b |
| (B) -0.13 = Retained Earnings (Balance) -1.67b / Total Assets 12.75b |
| (C) -0.12 = EBIT TTM -1.54b / Avg Total Assets 13.32b |
| (D) -0.57 = Book Value of Equity -1.91b / Total Liabilities 3.37b |
| Total Rating: -0.02 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 47.80
| 1. Piotroski 3.50pt |
| 2. FCF Yield 0.55% |
| 3. FCF Margin 3.87% |
| 4. Debt/Equity 0.14 |
| 5. Debt/Ebitda 0.07 |
| 6. ROIC - WACC (= -26.93)% |
| 7. RoE -17.51% |
| 8. Rev. Trend 82.34% |
| 9. EPS Trend 38.03% |
What is the price of SNDK shares?
Over the past week, the price has changed by +29.26%, over one month by +107.96%, over three months by +235.78% and over the past year by +1292.47%.
Is SNDK a buy, sell or hold?
- Strong Buy: 5
- Buy: 1
- Hold: 5
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the SNDK price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 284.7 | -43.2% |
| Analysts Target Price | 284.7 | -43.2% |
| ValueRay Target Price | 569.7 | 13.7% |
SNDK Fundamental Data Overview January 17, 2026
P/S = 7.1093
P/B = 5.896
Revenue TTM = 7.78b USD
EBIT TTM = -1.54b USD
EBITDA TTM = -1.40b USD
Long Term Debt = 1.33b USD (from longTermDebt, last quarter)
Short Term Debt = 20.0m USD (from shortTermDebt, last quarter)
Debt = 1.35b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -91.0m USD (from netDebt column, last quarter)
Enterprise Value = 55.22b USD (55.31b + Debt 1.35b - CCE 1.44b)
Interest Coverage Ratio = -20.06 (Ebit TTM -1.54b / Interest Expense TTM 77.0m)
EV/FCF = 183.5x (Enterprise Value 55.22b / FCF TTM 301.0m)
FCF Yield = 0.55% (FCF TTM 301.0m / Enterprise Value 55.22b)
FCF Margin = 3.87% (FCF TTM 301.0m / Revenue TTM 7.78b)
Net Margin = -22.37% (Net Income TTM -1.74b / Revenue TTM 7.78b)
Gross Margin = 27.93% ((Revenue TTM 7.78b - Cost of Revenue TTM 5.61b) / Revenue TTM)
Gross Margin QoQ = 29.77% (prev 26.20%)
Tobins Q-Ratio = 4.33 (Enterprise Value 55.22b / Total Assets 12.75b)
Interest Expense / Debt = 1.18% (Interest Expense 16.0m / Debt 1.35b)
Taxrate = 9.68% (12.0m / 124.0m)
NOPAT = -1.40b (EBIT -1.54b * (1 - 9.68%)) [loss with tax shield]
Current Ratio = 3.29 (Total Current Assets 4.98b / Total Current Liabilities 1.52b)
Debt / Equity = 0.14 (Debt 1.35b / totalStockholderEquity, last quarter 9.38b)
Debt / EBITDA = 0.07 (negative EBITDA) (Net Debt -91.0m / EBITDA -1.40b)
Debt / FCF = -0.30 (Net Debt -91.0m / FCF TTM 301.0m)
Total Stockholder Equity = 9.94b (last 4 quarters mean from totalStockholderEquity)
RoA = -13.06% (Net Income -1.74b / Total Assets 12.75b)
RoE = -17.51% (Net Income TTM -1.74b / Total Stockholder Equity 9.94b)
RoCE = -13.71% (EBIT -1.54b / Capital Employed (Equity 9.94b + L.T.Debt 1.33b))
RoIC = -12.28% (negative operating profit) (NOPAT -1.40b / Invested Capital 11.36b)
WACC = 14.65% (E(55.31b)/V(56.66b) * Re(14.98%) + D(1.35b)/V(56.66b) * Rd(1.18%) * (1-Tc(0.10)))
Discount Rate = 14.98% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 81.65 | Cagr: 1.72%
[DCF Debug] Terminal Value 46.68% ; FCFF base≈301.0m ; Y1≈197.6m ; Y5≈90.2m
Fair Price DCF = 6.45 (EV 853.9m - Net Debt -91.0m = Equity 944.9m / Shares 146.6m; r=14.65% [WACC]; 5y FCF grow -40.0% → 2.90% )
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: 38.03 | EPS CAGR: 103.1% | SUE: N/A | # QB: 0
Revenue Correlation: 82.34 | Revenue CAGR: 22.70% | SUE: N/A | # QB: 0
EPS next Quarter (2026-03-31): EPS=3.80 | Chg30d=+0.187 | Revisions Net=+2 | Analysts=16
EPS current Year (2026-06-30): EPS=13.30 | Chg30d=+0.370 | Revisions Net=+3 | Growth EPS=+344.8% | Growth Revenue=+44.8%
EPS next Year (2027-06-30): EPS=22.18 | Chg30d=+1.681 | Revisions Net=+4 | Growth EPS=+66.8% | Growth Revenue=+25.5%
Additional Sources for SNDK Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle